Overview
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Criteria
Inclusion Criteria:- Corneal and conjunctival damage
- Insufficiency of lacrimal secretion
- Ocular symptom
Exclusion Criteria:
- Severe ophthalmic disorder
- Punctual plugs or surgery for occlusion of the lacrimal puncta